<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2015122222498N6</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2016-08-02</date_registration>
      <primary_sponsor>Vice chancellor for research, Islamic Azad University, Rasht,  Science and Research Branch</primary_sponsor>
      <public_title>Comparison the effect of a period combination resistance-endurance exercise training on body composition, blood lipid profile, and blood glucose homeostasis in overweight and obese high school girls</public_title>
      <acronym></acronym>
      <scientific_title>Comparison the effect of a period  combination resistance-endurance exercise training on body composition, blood lipid profile, and blood glucose homeostasis in overweight and obese high school girls</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2015-03-15</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/19388</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Other design features: Randomization was performed  using to sealed envelopes.</study_design>
      <phase>1-2</phase>
      <hc_freetext>Obesity.</hc_freetext>
      <i_freetext>Intervention 1: The experimental group did combined training (strength and endurance). The exercise conducted about 12 week for 90 minutes.Endurance training was with Intensity 50 to 80 percent heart rate. Training  did on bike and treadmill. Resistance training was with&#13;
50 to 70 percent heart rate. Intervention 2: Control group was without practice.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Marzieh Nazari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Lakan gate, Azad University, Rasht Branch, Rasht, Guilan</address>
        <city>Rasht</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+1 333423308</telephone>
        <email>m_nazari1390@yahoo.com</email>
        <affiliation>Islamic Azad University, Rasht Branch</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr.Ramin Shabani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Lakan Gate, Islamic Azad University, Rasht Branch, Rasht</address>
        <city>Rasht</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+1 333423308</telephone>
        <email>shabani_msn@yahoo.com</email>
        <affiliation>Islamic Azad University Of Rasht Branch</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria are: Lack exercise training in one years a go; Maximum age 13-15 years. exclusion criteria are: Patients with Acute cardiovascular disease and Joint and bone diseases</inclusion_criteria>
      <agemin>13 years</agemin>
      <agemax>15 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E66.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Obesity and other hyperalimentation</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Lifestyle</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The experimental group did combined training (strength and endurance). The exercise conducted about 12 week for 90 minutes.Endurance training was with Intensity 50 to 80 percent heart rate. Training  did on bike and treadmill. Resistance training was with&#13;
50 to 70 percent heart rate.</i_keyword>
      <i_keyword>Control group was without practice</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Fasting blood glucose (FBS). Timepoint: before and after 12 weak exercise. Method of measurement: According mg/dl and Blood samples.</prim_outcome>
      <prim_outcome>Insulin resistance. Timepoint: before and after 12 weak exercise. Method of measurement: It was measured with HOMA-IR index.</prim_outcome>
      <prim_outcome>Insulin. Timepoint: before and after 12 weak exercise. Method of measurement: According mg/dl and Blood samples.</prim_outcome>
      <prim_outcome>Triglycerides. Timepoint: before and after 12 weak exercise. Method of measurement: According mg/dl and Blood samples.</prim_outcome>
      <prim_outcome>Total Cholesterol. Timepoint: before and after 12 weak exercise. Method of measurement: According mg/dl and Blood samples.</prim_outcome>
      <prim_outcome>High-density lipoprotein. Timepoint: before and after 12 weak exercise. Method of measurement: According mg/dl and Blood samples.</prim_outcome>
      <prim_outcome>Low-density lipoprotein. Timepoint: before and after 12 weak exercise. Method of measurement: According mg/dl and Blood samples.</prim_outcome>
      <prim_outcome>Glycosylated hemoglobin. Timepoint: before and after 12 weak exercise. Method of measurement: According mg/dl and Blood samples.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Weight. Timepoint: before and after 12 weak exercise. Method of measurement: According to kilograms and by balance.</sec_outcome>
      <sec_outcome>Body mass index. Timepoint: before and after 12 weak exercise. Method of measurement: According to Kg/m2 and dividing body weight  by the square of the height(m2).</sec_outcome>
      <sec_outcome>Subcutaneous fat. Timepoint: before and after 12 weak exercise. Method of measurement: By caliper.</sec_outcome>
      <sec_outcome>Body Fat Percentage. Timepoint: before and after 12 weak exercise. Method of measurement: By caliper.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice chancellor for research, Islamic Azad University, Rasht,  Science and Research Branch</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2015-04-25</approval_date>
        <contact_name>Ethics Committee of Islamic Azad University, Rasht, Science and Research  Branch</contact_name>
        <contact_address>Lakan Gate, Azad University, Rasht Branch, Rasht Rasht  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
